Aescap Ventures

Aescap 2.0 is a biotech fund that invests in publicly traded biotech companies. It invests in high-growth, highly innovative companies that develop and market new medicines and, to a lesser extent, diagnostics and/or medical devices. Aescap 2.0 has around 220 million euro under management and has made a net performance of more than 17% over its five years of existence. Entry into and exit from this biotech fund is possible twice per month.

© Copyright 2021 - Ready2Scale